Dianthus Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 6.43 M | $265.04 M | 7.72% | 17.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.50 M | $103.16 M | -2.89% | 6.62% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 2.42 M | $99.59 M | 0.00% | 6.39% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 2.14 M | $88.07 M | -35.38% | 5.65% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 2.10 M | $86.71 M | -34.33% | 5.57% |
| VANGUARD GROUP INC | 01/29/2026 | 2.05 M | $84.42 M | 24.74% | 5.42% |
| BLACKROCK, INC. | 02/12/2026 | 1.92 M | $78.93 M | 42.92% | 5.07% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 1.68 M | $69.09 M | 0.00% | 4.44% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 1.61 M | $66.42 M | -43.78% | 4.26% |
| STATE STREET CORP | 02/13/2026 | 1.51 M | $62.13 M | 124.67% | 3.99% |
| BRAIDWELL LP | 02/17/2026 | 1.27 M | $52.50 M | 52.56% | 3.37% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.17 M | $48.05 M | -42.89% | 3.09% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.07 M | $44.05 M | 5.47% | 2.83% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.01 M | $41.56 M | 76.03% | 2.67% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.00 M | $41.40 M | 34.32% | 2.66% |
| VR ADVISER, LLC | 02/17/2026 | 1.00 M | $41.21 M | 4.08% | 2.65% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 834.38 K | $34.38 M | -2.11% | 2.21% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 789.76 K | $32.55 M | 0.00% | 2.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 750.14 K | $30.91 M | 11.14% | 1.98% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/17/2026 | 743.59 K | $30.64 M | -43.49% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 676.66 K | $27.89 M | 26.14% | 1.79% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 667.22 K | $27.50 M | 356.48% | 1.77% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 653.57 K | $26.93 M | -2.10% | 1.73% |
| TRI LOCUM PARTNERS LP | 02/17/2026 | 622.40 K | $25.65 M | 240.36% | 1.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 616.03 K | $25.39 M | 185.02% | 1.63% |
| UBS GROUP AG | 01/29/2026 | 606.62 K | $25.00 M | 342.55% | 1.61% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 577.02 K | $23.78 M | 163.75% | 1.53% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 475.75 K | $19.61 M | 1,275.28% | 1.26% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 474.50 K | $19.55 M | -17.87% | 1.26% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 465.54 K | $19.18 M | 158.60% | 1.23% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 462.83 K | $19.07 M | 2.78% | 1.22% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 375.00 K | $15.45 M | 0.00% | 0.99% |
| VIVO CAPITAL, LLC | 02/13/2026 | 354.00 K | $14.59 M | 0.00% | 0.94% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 350.00 K | $14.42 M | 31.68% | 0.93% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 315.00 K | $12.98 M | 57.50% | 0.83% |
| CANDRIAM S.C.A. | 02/13/2026 | 311.15 K | $12.82 M | 3.23% | 0.82% |
| 02/13/2026 | 297.44 K | $12.26 B | 100.00% | 0.79% | |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 275.00 K | $11.33 M | 83.33% | 0.73% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 264.69 K | $10.91 M | 0.00% | 0.70% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 250.81 K | $10.34 M | 29.91% | 0.66% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 246.79 K | $10.17 M | 100.00% | 0.65% |
| IRON TRIANGLE PARTNERS LP | 02/17/2026 | 230.73 K | $9.51 M | 100.00% | 0.61% |
| MORGAN STANLEY | 02/13/2026 | 228.02 K | $9.40 M | 194.14% | 0.60% |
| WOODLINE PARTNERS LP | 02/17/2026 | 213.09 K | $8.78 M | 399.06% | 0.56% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 210.67 K | $8.68 M | 2,324.59% | 0.56% |
| NORTHERN TRUST CORP | 02/17/2026 | 207.25 K | $8.54 M | 31.56% | 0.55% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 207.12 K | $8.54 M | 100.00% | 0.55% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 205.82 K | $8.48 M | 45.83% | 0.54% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 205.09 K | $8.45 M | 88.64% | 0.54% |
| NUVEEN, LLC | 02/12/2026 | 190.62 K | $7.86 M | 340.82% | 0.50% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dianthus Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 188 institutional investors and hedge funds held shares of Dianthus Therapeutics Inc. The most heavily invested institutionals were:
FMR LLC: 6.43 M
WELLINGTON MANAGEMENT GROUP LLP: 2.5 M
Octagon Capital Advisors LP: 2.42 M
Fairmount Funds Management LLC: 2.14 M
Avidity Partners Management LP: 2.1 M
VANGUARD GROUP INC: 2.05 M
129.97% of Dianthus Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 50.45 M shares in the last 24 months. This purchase volume represents approximately $2.65 B in transactions.